About: Aspirin Inhibition of Platelet Activation Pathway

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Aspirin Inhibition of Platelet Activation Pathway Goto Sponge Distinct Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	Class
rdfs:label	Aspirin Inhibition of Platelet Activation Pathway
rdfs:subClassOf	Drug Pathway
Semantic_Type	Functional Concept
Preferred_Name	Aspirin Inhibition of Platelet Activation Pathway
UMLS_CUI	C1516047
BioCarta_ID	h_sppaPathway
ALT_DEFINITION	Activation of the protease-activated GPCRs in platelets contributes to platelet activation in clotting. The protease-activated receptors PAR1 and PAR4 are cleaved by the protease thrombin, releasing a tethered peptide ligand that activates the receptor and triggers intracellular calcium release. Platelets from mice lacking the PAR4 gene are not activated by thrombin and are impaired in clotting, supporting the importance of thrombin signaling through PAR4 in clotting. Human platelets express both PAR1 and PAR4, with PAR1 playing a more dominant role in clotting in humans. Calcium release induced by PARs activates PKC, modulating integrin alpha IIB beta 3 (glycoprotein IIb/IIIa) and opening integrin ligand binding sites to contribute to platelet aggregation. Intracellular calcium increases induced by thrombin activate phospholipase A2, liberating arachidonic acid, the first step in prostaglandin and thromboxane biosynthesis. Ras/Map kinase activation by the PAR receptors also activates phospholipase A2. The activation of PAR-induced platelet aggregation is inhibited by aspirin, indicating that thromboxane production induced by PAR signaling contributes to platelet activation. Arachidonic acid is converted to the prostaglandin PGG2 by the enzyme Cox-1 in platelets, and Cox-1 is inhibited by aspirin, reducing thromboxane A2 production by platelets. Thromboxane is a potent vasoconstrictor and platelet activator, so inhibition of Cox-1 in platelets by aspirin may explain some of the cardioprotective actions of aspirin.BIOCARTA
Legacy_Concept_Name	Aspirin_Inhibition_of_Platelet_Activation_Pathway
FULL_SYN	Aspirin Inhibition of Platelet Activation PathwayPTNCI Aspirin Blocks Signaling Pathway Involved in Platelet ActivationPTBIOCARTA
code	C39235
is someValuesFrom of	nodeID://b664785 nodeID://b671726 nodeID://b674231 nodeID://b674784 nodeID://b675314 nodeID://b675386 nodeID://b677786 nodeID://b678873 nodeID://b688284 nodeID://b688553 nodeID://b688639 nodeID://b689046 nodeID://b689141 nodeID://b693236 nodeID://b699733 nodeID://b700688 nodeID://b701072 nodeID://b701160 nodeID://b704538 nodeID://b705161 nodeID://b705702 nodeID://b706282 nodeID://b706333 nodeID://b710893 nodeID://b711423 nodeID://b713621 nodeID://b726285 nodeID://b726494

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software